Gut microbiota and uveitis: exploring novel mechanisms of inflammatory ocular diseases via the gut-eye axis
Frontiers in Microbiology · 22.04.2026 · 17
DOI: 10.3389/fmicb.2026.1749111 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 22.04.2026. Verfasst von Qing Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Provincial Key Laboratory of Traditional Chinese Medicine Diagnostics, Hunan University of Chinese Medicine, Changsha, Hunan, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Uveitis is an inflammatory ocular condition that primarily affects young adults and is often associated with systemic and autoimmune disorders. This disease primarily affects intraocular structures such as the iris, ciliary body, and choroid. Clinically, it manifests through a series of symptoms, including eye redness, pain, and blurred vision, which significantly impact the quality of life for patients worldwide. Recently, the role of gut microbiota (GM) in the immune regulation and pathogenesis of inflammatory diseases has garnered significant scientific interest. This study aimed to investigate the potential association between GM and uveitis, with the objective of demonstrating novel mechanisms underlying inflammatory ocular diseases through the emerging concept of the “gut-eye axis.” Current research suggests that gut dysbiosis may influence the immune status of distal organs via various pathways, including molecular mimicry, modulation by microbial metabolites, disruption of intestinal immune homeostasis, and compromise of the intestinal mucosal barrier. Building on these mechanisms, we further explored innovative therapeutic strategies targeting GM and its metabolites, including probiotics, prebiotics, antibiotics, immunomodulators, phage therapy, fecal microbiota transplantation, and dietary interventions. This review systematically examined the association between GM dysbiosis and uveitis pathogenesis, offering new insights and directions for future research in this emerging field and establishing a theoretical foundation for developing targeted therapies based on the modulation of the microbiome.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hunan Provincial Key Laboratory of Traditional Chinese Medicine Diagnostics, Hunan University of Chinese Medicine, Changsha, Hunan, China.
- School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
- School of Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
Zitieren
APA
Gao, Q., Xiong, M., Zhou, S., Lu, J., Ren, B., Peng, Q., Zeng, M., & Song, H. (2026). Gut microbiota and uveitis: exploring novel mechanisms of inflammatory ocular diseases via the gut-eye axis. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1749111
Vancouver
Gao Q, Xiong M, Zhou S, Lu J, Ren B, Peng Q, et al. Gut microbiota and uveitis: exploring novel mechanisms of inflammatory ocular diseases via the gut-eye axis. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1749111
BibTeX
@article{Gao2026,
author = {Gao, Qing and Xiong, Meng and Zhou, Shunhua and Lu, Jing and Ren, Baoping and Peng, Qinghua and Zeng, Meiyan and Song, Houpan},
title = {Gut microbiota and uveitis: exploring novel mechanisms of inflammatory ocular diseases via the gut-eye axis},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1749111}
}
EUVIMED